Vivani Medical Inc
NASDAQ:VANI

Watchlist Manager
Vivani Medical Inc Logo
Vivani Medical Inc
NASDAQ:VANI
Watchlist
Price: 1.34 USD 0.75% Market Closed
Market Cap: 74m USD
Have any thoughts about
Vivani Medical Inc?
Write Note

Vivani Medical Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivani Medical Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Vivani Medical Inc
NASDAQ:VANI
Change in Working Capital
$545k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Change in Working Capital
-$168m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Change in Working Capital
-$845m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Change in Working Capital
-$873m
CAGR 3-Years
-79%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Change in Working Capital
-$1.7B
CAGR 3-Years
-45%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Change in Working Capital
-$1.2B
CAGR 3-Years
-64%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
No Stocks Found

Vivani Medical Inc
Glance View

Market Cap
74m USD
Industry
Health Care

Vivani Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Emeryville, California and currently employs 15 full-time employees. The company went IPO on 2014-11-19. Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The firm is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The firm's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The firm's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.

VANI Intrinsic Value
0.45 USD
Overvaluation 66%
Intrinsic Value
Price

See Also

What is Vivani Medical Inc's Change in Working Capital?
Change in Working Capital
545k USD

Based on the financial report for Jun 30, 2024, Vivani Medical Inc's Change in Working Capital amounts to 545k USD.

Back to Top